Viking Therapeutics (VKTX) Net Cash Flow (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Net Cash Flow came in at $7.8 million in Q2 2026, up 293.8% year-over-year from $2.0 million in Q2 2025, and up 116.44% quarter-over-quarter from -$47.7 million in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Net Cash Flow (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Net Cash Flow across 13 years of filings, most recently posting $7.8 million for Q2 2026.
- In Q2 2026, Net Cash Flow rose 293.8% year-over-year to $7.8 million; the TTM figure through Jun 2026 stood at $92.1 million (up 1027.95% YoY), while the FY2025 annual figure was $139.1 million, up 584.95% from the prior year.
- Net Cash Flow came in at $7.8 million for Q2 2026 at Viking Therapeutics, up from -$47.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $140.1 million in Q1 2024 to a low of -$151.7 million in Q2 2024.
- Average Net Cash Flow over 5 years is $5.6 million, with a median of $6.8 million recorded in 2022.
- Year-over-year, Net Cash Flow soared 1195.85% in 2023 and sank 523.6% in 2026.
- Over 5 years, Net Cash Flow stood at $7.1 million in 2022, then soared by 158.1% to $18.3 million in 2023, then plunged by 229.08% to -$23.6 million in 2024, then jumped by 377.26% to $65.4 million in 2025, then sank by 88.01% to $7.8 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were $7.8 million in Q2 2026, -$47.7 million in Q1 2026, and $65.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -94.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -4.43 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -722.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 652.90 Mn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | 7.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.85 Mn |
| Mar 31, 2026 | -47.71 Mn |
| Dec 31, 2025 | 65.43 Mn |
| Sep 30, 2025 | 66.50 Mn |
| Jun 30, 2025 | -4.05 Mn |
| Mar 31, 2025 | 11.26 Mn |
| Dec 31, 2024 | -23.60 Mn |
| Sep 30, 2024 | 6.46 Mn |
| Jun 30, 2024 | -151.67 Mn |
| Mar 31, 2024 | 140.11 Mn |
| Dec 31, 2023 | 18.28 Mn |
| Sep 30, 2023 | -32.27 Mn |
| Jun 30, 2023 | 51.16 Mn |
| Mar 31, 2023 | -18.26 Mn |
| Dec 31, 2022 | 7.08 Mn |
| Sep 30, 2022 | 13.41 Mn |
| Jun 30, 2022 | 3.95 Mn |
| Mar 31, 2022 | -13.92 Mn |
| Dec 31, 2021 | 15.11 Mn |
| Sep 30, 2021 | 2.44 Mn |
API Access
Viking Therapeutics Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();